Triptan nonresponders: Do they exist and who are they?

Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

(2012) et al.   CEPHALALGIA

The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients

(2010) Salvatore Terrazzino et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Allodynia-Associated Symptoms, Pain Intensity and Time to Treatment: Predicting Treatment Response in Acute Migraine Intervention

(2009) Roger K. Cady et al.   HEADACHE

Impact of Recent Prior Opioid Use on Rizatriptan Efficacy. A Post Hoc Pooled Analysis

(2009) Tony W. Ho et al.   HEADACHE

Fixed-Dose Sumatriptan and Naproxen in Poor Responders to Triptans With a Short Half-Life

(2009) Ninan T. Mathew et al.   HEADACHE

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

(2008) PJ Goadsby et al.   CEPHALALGIA

Pathways to the Best Fit of Triptans for Migraine Patients

(2008) MG Buzzi   CEPHALALGIA